Karen H. Lu, MD, Chair

The University of Texas M.D. Anderson Cancer Center

LuDr. Lu is Professor and Vice Chair of Prevention and Biomarker Research in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas M.D. Anderson Cancer Center, and also hold the H.E.B. Professorship of Cancer Research. She is Director of the Uterine Cancer Research Program and Principal Investigator of the Uterine Cancer Specialized Program of Research Excellence (SPORE), a large $10 million NIH grant focused on the prevention and treatment of Uterine Cancer.

She completed her gynecologic oncology fellowship at Brigham and Women’s Hospital/ Dana-Farber Cancer Institute. In addition to treating gynecologic cancer patients, she participates in research to apply laboratory-based findings to improving the care of uterine and ovarian cancer patients. She has received support for her research from the National Cancer Institute, the Lynne Cohen Foundation, the American Gynecologic and Obstetric Society, and the Ovarian Cancer Research Fund. Dr. Lu is also an international expert in hereditary gynecologic cancers, and co-directs the Clinical Cancer Genetics Program at MD Anderson.

Spotlight

SGO, ASCCP Clarify Recommendations of Primary HPV Testing for Cervical Cancer Screening. Read the release.

Awareness

2015 National Race to End Women’s Cancer Chair Camille Grammer wants all women to know the symptoms of uterine cancer.

Research

The Foundation’s research award winners will be announced in March. Thank you to all who sent in their applications.

Education

The next Ovarian Cancer Survivors Course is Feb. 28 in West Palm Beach, FL. For more information, click here.